Watching for the Patient With AF: Latest Advances and Technologies
Program Goals
Patient Interview
Risk of Stroke for Patients With AF
Challenges Associated With Anticoagulant Therapy
Patients at Risk for Bleeding
Stroke Risk From AF
PROTECT AF Study (N = 800)
The PREVAIL Trial
WATCHMAN: Meta-Analysis
Procedural Events
EWOLUTION Registry
Post-Approval US Experience
PROTECT and PREVAIL: Pooled, Patient-Level Analysis
PROTECT and PREVAIL: Pooled, Patient-Level Analysis (cont)
Other Devices
ASAP-TOO
FDA Approval
CMS Requirements
Talking to Patient
Procedure Team
Summary
Summary (cont)